Luba Yammine

Credentials: · · · ·

History

Treating Alcohol Use Disorders in Primary Care with Semaglutide: Leveraging a Randomized Bayesian Adaptive Enrichment Design
National Institute on Alcohol Abuse and Alcoholism · R01
PI · $842.2K · University of Texas Hlth Sci Ctr Houston
2026–2031
Repurposing Semaglutide for the Treatment of Cocaine Use Disorder: A Pilot Mechanistic Study
National Institute on Drug Abuse · R01
Contact PI · $1.4M · University of Texas Hlth Sci Ctr Houston
2025–2029
A Randomized Controlled Trial of Exenatide as an Adjunct to Nicotine Patch for Smoking Cessation and Prevention of Post-Cessation Weight Gain
National Institute on Drug Abuse · R01
Contact PI · $2.2M · University of Texas Hlth Sci Ctr Houston
2022–2027

Repurposing Semaglutide for the Treatment of Cocaine Use Disorder
Principal investigator · Recruiting · Phase 2
The University of Texas Health Science Center, Houston
2026–2029
Semaglutide for Post-Smoking Cessation Weight Management
Principal investigator · Recruiting · Phase 2
The University of Texas Health Science Center, Houston
2024–2028
Exenatide for Smoking Cessation and Prevention of Weight Gain
Principal investigator · Completed · Phase 2
The University of Texas Health Science Center, Houston
2022–2026
Exenatide for Treating Cocaine Use Disorder
Principal investigator · Completed · Phase 1, Phase 2
The University of Texas Health Science Center, Houston
2021